INCYTE CORP
- CIK: 0000879169
- EIN: 94-3136539
- Business address: 1801 AUGUSTINE CUT-OFF, WILMINGTON, Delaware, 19803
About INCYTE CORP
INCYTE CORP (CIK: 0000879169) is an American company incorporated in the state of Delaware. Head office is located at 1801 AUGUSTINE CUT-OFF, WILMINGTON, Delaware, 19803. Work in the industry 8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH. INCYTE CORP is a public company and trade via Over-The-Counter (OTC).Old names:
- INCYTE INC from 2003-28-Mar to 2003-28-Mar
- INCYTE GENOMICS INC from 2000-03-Aug to 2003-25-Feb
- INCYTE PHARMACEUTICALS INC from 1994-07-Jun to 2000-18-Apr
Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Denton Sheila A. | 0001995298 | Oct-02-2023 | officer: EVP & General Counsel |
| HARRIGAN EDMUND | 0001177917 | Sep-29-2023 | director |
| Clancy Paul J | 0001409601 | Sep-29-2023 | director |
| CAGNONI PABLO J | 0001205703 | Jun-07-2023 | officer: President, R&D |
| Schaffert Susanne | 0001938363 | Oct-01-2022 | director |
| Tray Thomas | 0001912317 | Mar-11-2022 | officer: Principal Accounting Officer |
| BRAWLEY OTIS W | 0001213029 | Sep-27-2021 | director |
| High Katherine A | 0001631248 | Mar-26-2020 | director |
| Dickinson Jonathan Elliott | 0001780561 | Jun-19-2019 | officer: EVP, General Manager, Europe |
| Morrissey Michael James | 0001780915 | Jun-19-2019 | officer: EVP, Head of Tech. Operations |
| Stamoulis Christiana | 0001502917 | Feb-11-2019 | officer: EVP & Chief Financial Officer |
| Dhanak Dashyant | 0001760682 | Dec-10-2018 | officer: EVP & Chief Scientific Officer |
| Pasquale Maria E | 0001736295 | Apr-09-2018 | officer: EVP & General Counsel |
| FOUSE JACQUALYN A | 0001405288 | Nov-14-2017 | director |
| Iyengar Vijay K | 0001670000 | May-09-2016 | officer: EVP GPS, BD, & Licensing |
| Stein Steven H | 0001673776 | May-02-2016 | officer: EVP & Chief Medical Officer |
| Trower Paul | 0001642041 | May-04-2015 | officer: VP, Finance & Prin Acc Officer |
| BIENAIME JEAN JACQUES | 0001221590 | Jan-20-2015 | director |
| GRYSKA DAVID W | 0001202335 | Oct-31-2014 | officer: Executive Vice President, CFO |
| Wenqing Yao | 0001624033 | Oct-22-2014 | officer: Ex VP Discovery Medicinal Chem |
| Flannelly Barry P | 0001615842 | Aug-11-2014 | officer: See Remarks |
| Huber Reid M | 0001607052 | Apr-27-2014 | officer: Exec VP & Chief Scientific Off |
| Hoppenot Herve | 0001596492 | Jan-13-2014 | director, officer: President and CEO |
| Baker Bros. Advisors (GP) LLC | 0001580575 | Jul-01-2013 | director, 10 percent owner |
| Baker Brothers Life Sciences LP | 0001363364 | Jun-11-2013 | director |
| 14159, L.P. | 0001551138 | Jun-11-2013 | director |
| 667, L.P. | 0001551139 | Jun-11-2013 | director |
| Daly James M | 0001560782 | Oct-22-2012 | officer: Exec. VP & Chief Comm. Officer |
| FBB Associates | 0001534842 | Jun-15-2012 | director, 10 percent owner |
| FBB2 LLC | 0001552222 | Jun-15-2012 | director, 10 percent owner |
| BAKER BROS ADVISORS LLC | 0001263508 | Apr-12-2012 | director, 10 percent owner |
| Siegel Eric H. | 0001527573 | Aug-08-2011 | officer: EVP, General Counsel |
| DIXON WENDY L | 0001202283 | May-21-2010 | director |
| Friedman Steven M. | 0001454964 | Jan-27-2009 | officer: EVP, Biology & Preclinical Dev |
| Levy Richard S | 0001454983 | Jan-27-2009 | officer: EVP, Chief Drug Dev&Medical Of |
| Andrews Patricia S | 0001445710 | Oct-21-2008 | officer: Chief Commercial Officer |
| BAKER FELIX | 0001087940 | Jan-04-2008 | director, 10 percent owner |
| Baker / Tisch Capital (GP), LLC | 0001244392 | Nov-09-2007 | director |
| Baker Biotech Capital (GP), LLC | 0001244389 | Aug-01-2007 | director |
| Baker Brothers Life Sciences Capital (GP), LLC | 0001307729 | Aug-01-2007 | director |
| 14159 capital (GP), LLC | 0001317493 | Aug-01-2007 | director |
| Baker Bros. Capital (GP), LLC | 0001244390 | Jan-31-2007 | director |
| NIBLACK JOHN F | 0001174456 | May-23-2006 | director |
| Emmens Matthew | 0001298332 | May-23-2006 | director |
| BAKER JULIAN | 0001087939 | Apr-25-2006 | director |
| PLATINUM ASSET MANAGEMENT LTD | 0001256071 | Apr-18-2006 | 10 percent owner |
| Chardonnet Laurent | 0001329010 | Jun-01-2005 | officer: VP Finance and Treasurer |
| HURLEY SCOTT W | 0001112249 | Jan-19-2005 | other: VP/Corp Controller & Treasurer |
| METCALF BRIAN W | 0001234564 | Jan-18-2005 | other: EVP/Chief Drug Dscvy Scientist |
| SWAIN PAULA J | 0001236934 | Jan-18-2005 | other: Exec VP, Human Resources |
| HASTINGS DAVID C | 0001237401 | Jan-18-2005 | officer: Exec VP & CFO |
| KELLER JOHN A | 0001263380 | Jan-18-2005 | officer: Exec VP & Chief Bus Officer |
| SCHRECK PATRICIA A | 0001271799 | Jan-18-2005 | officer: EVP and General Counsel |
| FRIEDMAN PAUL A | 0001236927 | Aug-16-2004 | director, officer: Chief Executive Officer |
| WHITFIELD ROY A | 0000936728 | May-25-2004 | director, other: Chairman |
| CRAVES FRED B | 0001014095 | May-25-2004 | director |
| DE SCHUTTER RICHARD U | 0001083205 | May-25-2004 | director |
| BROOKE PAUL A | 0001175940 | May-25-2004 | director |
| ARIKO BARRY A | 0001197391 | May-25-2004 | director |
| SAXE JON S | 0001114914 | Mar-30-2004 | director |
| TISCH ANDREW H | 0001009879 | Jan-14-2004 | 10 percent owner |
| TISCH JAMES S | 0001010178 | Jan-14-2004 | 10 percent owner |
| TISCH THOMAS J | 0001081916 | Jan-14-2004 | 10 percent owner |
| TISCH DANIEL R | 0001111794 | Jan-14-2004 | 10 percent owner |
| TISCH BONNIE J | 0001248920 | Jan-14-2004 | 10 percent owner |
| DAMIAL FOUNDATION INC | 0001276911 | Jan-14-2004 | 10 percent owner |
| BAKER BIOTECH CAPITAL II GP LLC | 0001244386 | Sep-19-2003 | 10 percent owner |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by INCYTE CORP
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000155 ( Act) Size: 0 KB |
Sep-16-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000154 ( Act) Size: 0 KB |
Sep-16-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-007036 (33 Act) Size: 0 KB |
Sep-13-2024 | 241297767 |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-006987 (33 Act) Size: 0 KB |
Sep-12-2024 | 241295165 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000151 ( Act) Size: 0 KB |
Aug-14-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-005954 (33 Act) Size: 0 KB |
Aug-12-2024 | 241197462 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000879169-24-000149 (34 Act) Size: KB |
Jul-30-2024 | 241157457 |
| 8-K | Document | Current report filing Acc-no: 0000879169-24-000146 (34 Act) Size: KB |
Jul-30-2024 | 241154376 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000143 ( Act) Size: 0 KB |
Jul-29-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-005602 (33 Act) Size: 0 KB |
Jul-25-2024 | 241142132 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-082289 ( Act) Size: KB |
Jul-24-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000139 ( Act) Size: 0 KB |
Jul-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000138 ( Act) Size: 0 KB |
Jul-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000137 ( Act) Size: 0 KB |
Jul-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000136 ( Act) Size: 0 KB |
Jul-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000135 ( Act) Size: 0 KB |
Jul-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000134 ( Act) Size: 0 KB |
Jul-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000133 ( Act) Size: 0 KB |
Jul-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000132 ( Act) Size: 0 KB |
Jul-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000879169-24-000131 ( Act) Size: 0 KB |
Jul-17-2024 |
Recent 20 filings. View all INCYTE CORP filings
Reviews
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Catherine
Thanks I look forward to using the product to improve my skin tone
Samuel Ejimofor
It's being easier working on the website. And I recommend, it's a great website
Frequently Asked Questions
Tags:
- INCYTE CORP overview
- INCYTE CORP job
- INCYTE CORP stock
- INCYTE CORP ownership
- INCYTE CORP CEO
- INCYTE CORP documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Zymergen Inc.
Update: Aug 26, 2022
XXSYS TECHNOLOGIES INC /CA
Update: Aug 25, 2022
WHISTLER INC
Update: Aug 25, 2022
WCG Clinical, Inc.
Update: Aug 25, 2022
Viventia Biotech Inc.
Update: Aug 24, 2022
VIACELL INC
Update: Aug 24, 2022
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 